Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3331769 | Hematology/Oncology Clinics of North America | 2009 | 16 Pages |
Abstract
In the 2008 World Health Organization-sponsored classification of hematopoietic and lymphoid malignancies, changes were made in the classification and criteria for the diagnosis of some of the myeloproliferative disorders. These changes were initiated by recent insights into the molecular pathogenesis of these disorders. In this article, the changes made to the myeloproliferative neoplasm and the basis of the new classification and altered diagnostic criteria are summarized and discussed.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
John Anastasi,